Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 40.35 Delayed Data As of 4:00pm ET |  +0.10 / +0.25%Today’s Change | 11.04 Today|||52-Week Range 41.15 | +132.56% Year-to-Date |
| Previous close | 40.25 |
| Today’s open | 40.05 |
| Day’s range | 40.00 - 40.85 |
| Volume | 206,487 |
| Average volume (3 months) | 155,752 |
| Market cap | $563.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +173.68% |
| Earnings growth (next 5 years) | +43.60% |
| Revenue growth (last year) | +24.58% |
| P/E ratio | 80.7 |
| Price/Sales | 2.02 |
| Price/Book | 9.09 |
| Today’s change | Today’s % change | |
|---|---|---|
| AXGNAxoGen Inc | -0.25 | -1.32% |
| ENTLEntellus Medical Inc | -0.39 | -2.25% |
| ---- | ||
| ARAYAccuray Inc | +0.05 | +1.11% |
| Next reporting date | November 6, 2017 |
| EPS forecast (this quarter) | $0.08 |
| Annual revenue (last year) | $118.1M |
| Annual profit (last year) | $2.6M |
| Net profit margin | 2.18% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director James A. Reinstein |
Chief Financial Officer Sandra A. Gardiner |
Corporate headquarters Brisbane, California |
